LID.L Share News (LID)

LID.L Information

There is currently no data for LID

LiDCO posts maiden profit

Tue, 24th Apr 2012 15:52

LiDCO, the blood movement monitoring company, announced its maiden post-tax profit although phasing issues with a major customer meant the numbers were not as impressive as the market had been expecting.The company made a loss of £45,000 before tax in the year to January 31st, versus a loss of £490,000 the year before. Once the tax man had chipped in with a sub of £60,000, however, the company's bottom line moved into the red, albeit by just £15,000. The previous year it had made a post-tax loss of £390,000.Revenue grew to £7.1m from £6.2m the year before.The market had been expecting a profit before tax of £0.23m on revenue of £7.43m, which may account for the shares shedding a halfpenny to 18p in the wake of the results.Finance director Paul Clifford explained to Sharecast that because the company's financial year was out of phase with the fiscal year of Covidien, its US distributor, LiDCO's annual revenue could be affected by timing issues which get ironed out over a longer period. Sales to Covidien clocked in at £1.8m, down from £2.4m the year before."Covidien order the same number of monitors from us every year, but depending on when they place that order, it could show up in this year's accounts or next year's, and we can't control that," Clifford said.Having said that, the two parties are moving to a quarterly order schedule which should minimise this "concertina" effect."The important thing to focus on is our disposable sales," Clifford claimed. "We work on the razor model: sell the razor blade, make the money on selling the blades."Revenue from disposables accounts for 70% of the group's total revenues and rose 36% year-on-year to £5.02m.The number of monitors installed during the period was 364, down from 524 additions the year before, but taking the installed base up to 2,189 units.The UK remains LiDCO's major market, largely because the country invests so much money in medical equipment. It is able to do this, Chief Executive Officer Terry O'Brien informed Sharecast, because of the policy of successive governments to consolidate health facilities, thus putting bigger budgets at their disposal.The closure of small local hospitals and the transfer of patients to better funded larger units often attracts the ire of local residents (and the local press) but O'Brien argued that it was a good thing because it enables the National Health Service (NHS) to invest in technology which, over the long run, saves the country money on the "prevention is better than cure" rule."The UK is the largest market in Europe [for hemodynamic monitoring] and was an early adopter of the technology, but it is not a story you often hear on the news. In contrast, a place like Germany, which has a lot of smaller hospitals, is a late adopter, and so is missing out," O'Brien maintained."The [UK] government is very interested in the technology of intra-operative hemodynamic [blood flow] monitoring, because it reduces the length of stay of patients in hospitals," O'Brien said.Full adoption of hemodynamic monitoring by the NHS for 750,000 additional patients per year is expected to save the NHS £400m per annum - assuming it is adopted, of course; O'Brien seems confident it will be and that other countries will follow.

More News

12 Feb 2014 10:53

LiDCO Expects To Swing To Pretax Profit In Full Year, As Expected

LONDON (Alliance News) - LiDCO Group PLC Wednesday said it expects pretax profit for the year ended January 31 to be in line with expectations, compared with a loss of GBP260,000 a year earlier. In a trading update ahead of its full-year results, the cardiovascular monitoring company said r

12 Feb 2014 08:25

UK MORNING BRIEFING: Telecity Drops 13% As Market Awaits BOE

LONDON (Alliance News) - Shares have opened mostly flat Wednesday, as the market awaits the Bank of England's Quarterly Inflation Report at 1030 GMT.

Telecity is holding back the FTSE 250. The data-centre provider is down 13% after announcing higher 2013 profit and

1 Oct 2013 08:47

LiDCO cash-flow positive as losses come down in first half

Surgical blood monitoring group LiDCO said it expected to be cash generative and profitable in the full year after slashing losses in the first half. Chief Executive Officer Terry O'Brien said the company had seen significant sales growth in the UK and export markets in the six months to end-July

26 Sep 2013 08:18

LiDCO Granted Graphical User Interface Patent By US Patent Office

4 Sep 2013 10:35

LiDCO receives approval from FDA

LiDCO, a cardiovascular monitoring company, said Wednesday that the US Food and Drug Administration (FDA) has cleared its CNSystems' continuous non-invasive blood pressure monitoring module for sale. The software enables the connection of modules to the LiDCOrapid cardiac output monitor allowing i

4 Sep 2013 09:13

LiDCo Says Blood Pressure System Using Its Montior Gets FDA Clearance

4 Sep 2013 08:18

STOCKS NEWS EUROPE-UK small caps outperform wider market

UK small caps and junior-listed AIM shares trade flat and up 0.1 percent respectively, outperforming the wider market where the mid-caps shed 0.6 percent and the blue chips trade 0.2 percent weaker. AIM-listed cardiovascular monitoring firm LiDCO Group advances almost 5 percent after the c

5 Jun 2013 16:09

STOCKS NEWS EUROPE-UK small caps fall less than broader market

The FTSE small-cap index and the junior FTSE Alternative Investment Market (AIM) all-share index both end 1.3 percent lower, outperforming a 1.8 percent fall for the mid caps and a 2.1 percent drop on the blue chips. Shares in VPhase fall 44 percent to 0.26 pence as the AIM-listed energy ef

5 Jun 2013 12:30

LiDCO surges on positive clinical trials

AIM-listed cardiovascular monitoring company LiDCO Group, has revealed that its LiDCOrapid blood monitoring system has been used successfully to monitor patients having major liver surgery. The hemodynamic system monitored cardiac output and guided intravenous fluid therapy in a randomised clinica

17 Dec 2012 07:45

LiDCO drives US expansion

Cardiovascular monitoring company LiDCO confirmed that it has acquired the existing LiDCOrapid customer base from Covidien, its previous US distribution partner, as it beefs up commercial opportunities in the US. After an initial integration and switch-over period the group expects associated rev

23 Aug 2012 16:00

Small caps round-up: Infrastructure India, SkyePharma, LiDCO Group

Infrastructure India, an AIM-listed investment group, pleased its investors with a 50.2 per cent leap in its net asset value (NAV) to 207.3m pounds over the year ended March. The value of the company's investments rose 94.9 per cent to 216.7m pounds, while the NAV per share climbed from 92p to 95p.

27 Oct 2011 06:54

Thursday tips round-up: BATs, CSR, Lidco...

British American Tobacco, the world's second-biggest maker of cigarettes, yesterday delivered a smoking set of results for the first nine months of this year, writes the Investment Column in the Independent. The volume of cigarettes sold by the group slipped by 0.4 per cent but BAT's ability to push

23 Aug 2011 13:58

LiDCO's sales to grow 18%

Cardiovascular monitoring company LiDCO expects revenue in the six months ended 31 July to be 18% ahead of the first half of 2010. The firm predicts sales to be at least £3.1m, compared to the £2.66m reported the year before, while losses are said to have been "significantly reduced". Pre-tax losse

20 Jul 2011 17:04

Premier Farnell director buys after shares wither

Premier Farnell non-executive director Paul Withers has taken advantage of a recent weak spell in the electrical components and industrial products supplier's share price, spending nearly £55,000. He took 30,000 shares at 183p a go, and now has 70,000. Shares in Premier Farnell took a dive earlier

Latest Share Chat

LID.L Share News (LID)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LiDCO posts maiden profit

Login to your account

Quickpicks are a member only feature

Login to your account